Design Therapeutics (DSGN) Payables (2020 - 2021)
Design Therapeutics' Payables history spans 2 years, with the latest figure at $3.3 million for Q3 2021.
- For Q3 2021, Payables changed N/A year-over-year to $3.3 million; the TTM value through Sep 2021 reached $3.3 million, changed N/A, while the annual FY2020 figure was $1.4 million, N/A changed from the prior year.
- Payables for Q3 2021 was $3.3 million at Design Therapeutics, up from $1.4 million in the prior quarter.
- Across five years, Payables topped out at $3.3 million in Q3 2021 and bottomed at $1.4 million in Q4 2020.